Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 78 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Carotid Atherosclerosis Clear all

Conditions: Cardiovascular Diseases, Metabolic Disease, Peripheral Artery Disease, Carotid Disease, Aneurysmal Disease, Venous Disease, Thrombosis, Lymphedema, Lipedema, Non-Atherosclerotic Chronic Arterial Occlusive Disease, Vasculitis, Fibromuscular Dysplasia, Arterial Dissection, May-Thurner Syndrome, Thoracic Outlet Syndrome, Vasospasm
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Timeline: 2019 – 2031
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Carotid Atherosclerosis
Interventions: Not listed
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Type 2 Diabetes
Interventions: Bydureon, placebo; Drug
Lead sponsor: Phoenix VA Health Care System; Federal
Eligibility: 21 Years to 75 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Atherosclerosis, Carotid Artery Plaque
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Carotid Atherosclerosis
Interventions: Perflutren; Diagnostic Test
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Carotid Artery Disease
Interventions: MRI with/without contrast; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cognitive Manifestations
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atherosclerosis
Interventions: K-604, Placebo; Drug · Other
Lead sponsor: Kowa Research Institute, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 19
States / cities: Chandler, Arizona • Litchfield Park, Arizona • Phoenix, Arizona + 16 more

Conditions: Carotid Stenosis
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Carotid Artery Diseases, Peripheral Arterial Disease
Interventions: Pegulicianine, Placebo; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease, Carotid Artery Disease, Peripheral Artery Disease
Interventions: Niacin, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atherosclerosis
Interventions: 17B-estradiol, Placebo; Drug · Other
Lead sponsor: University of Southern California; Other
Eligibility: Female only
Enrollment: 643 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Prevention of Subclinical Atherosclerosis Progression, Prevention of Cognitive Decline
Interventions: Nattokinase, Placebo; Dietary Supplement · Other
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 100 Years
Enrollment: 265 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Carotid Atherosclerosis, Cerebrovascular Accident, Diabetes Mellitus, Hypercholesterolemia, Hypertension
Interventions: cytokine and leukocyte activation profile; Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1993 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Carotid Atherosclerosis, Myocardial Infarction
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Atherosclerosis, Inflammation
Interventions: Sitagliptin, Placebo; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 40 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Carotid Atherosclerosis
Interventions: Cu[64]-25%-CANF-Comb PET-MR; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Atherosclerosis, Stroke
Interventions: Carotid Ultrasound; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 40 Years to 70 Years
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 5
States / cities: Fort Atkinson, Wisconsin • Janesville, Wisconsin • Oconomowoc, Wisconsin + 2 more

Conditions: Carotid Artery Diseases, Aortic Diseases, Peripheral Arterial Diseases
Interventions: Intergard Standard - Collagen Coated Vascular Grafts and Patches, Hemashield - Collagen Coated Vascular Grafts and Patches, Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches, Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts; Device
Lead sponsor: Intervascular; Industry
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Hershey, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Carotid Atherosclerosis
Interventions: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine), Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine); Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Atherosclerosis
Interventions: Cu[64]-25%CANF-Comb; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Vascular Disease
Interventions: Not listed
Lead sponsor: Montreal Heart Institute; Other
Eligibility: 18 Years and older
Enrollment: 1,339 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 16
States / cities: Los Angeles, California • Torrance, California • Fort Lauderdale, Florida + 13 more

Conditions: Aortic Aneurysm, Abdominal, Carotid Atherosclerosis
Interventions: 18F-FPPRGD2, Positron emission tomography, Computed tomography, Magnetic Resonance Imaging; Drug · Device · Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Atherosclerosis, Atherosclerotic Plaque, Carotid Stenosis
Interventions: Indocyanine green; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Vascular Lab Resource (VLR) Biorepository

RLIP76 in Human Serum in Adults With Rheumatologic Diseases

Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus

New Technologies to Determine Carotid Plaque Vulnerability

Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound

3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery

Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates

A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study

Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques

Assessment Of Vascular Health After Niacin Therapy (AVANT)

ELITE: Early Versus Late Intervention Trial With Estradiol

Nattokinase Atherothrombotic Prevention Study

Potential Risk Factors for Stroke

Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors

Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

PET Detection of CCR2 in Human Atherosclerosis

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)

Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes

Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation

Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque